Cost-Effectiveness of Remote Tailored Risk Communication and Navigation for Hereditary Genetic Risk Assessment Uptake: Economic Evaluation From the Genetic Risk Assessment for Cancer Education and Empowerment Trial
Implementing TCN in a clinic setting would come with notable costs, and current reimbursement policies for telemedicine may not be sufficient. Cost-effectiveness of TCN can be improved if subsequent interventions are more efficacious or are delivered to greater patient volumes.
Authors
- Elizabeth A. Handorf (ORCID: https://orcid.org/0000-0003-0445-8978)
- Jean A. McDougall (ORCID: https://orcid.org/0000-0003-3144-4387)
- Deborah Toppmeyer
- Jinghua An (ORCID: https://orcid.org/0000-0002-1650-3855)
- Scott T. Walters (ORCID: https://orcid.org/0000-0003-4074-6141)
- Emily Heidt (ORCID: https://orcid.org/0000-0002-6210-3422)
- Anita Y. Kinney (ORCID: https://orcid.org/0000-0002-2996-9355)
Institutions
- Rutgers, The State University of New Jersey (US)
- University of North Texas (US)
- University of North Texas Health Science Center (US)
- Fred Hutch Cancer Center (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1200/op-24-00617
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00